Cocrystal Pharma Stock Market Value
COCP Stock | USD 1.40 0.10 6.67% |
Symbol | Cocrystal |
Cocrystal Pharma Price To Book Ratio
Is Cocrystal Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cocrystal Pharma. If investors know Cocrystal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cocrystal Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.97) | Revenue Per Share 0.006 | Quarterly Revenue Growth 0.269 | Return On Assets (0.32) | Return On Equity (0.48) |
The market value of Cocrystal Pharma is measured differently than its book value, which is the value of Cocrystal that is recorded on the company's balance sheet. Investors also form their own opinion of Cocrystal Pharma's value that differs from its market value or its book value, called intrinsic value, which is Cocrystal Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cocrystal Pharma's market value can be influenced by many factors that don't directly affect Cocrystal Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cocrystal Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cocrystal Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cocrystal Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cocrystal Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cocrystal Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cocrystal Pharma.
02/27/2024 |
| 03/28/2024 |
If you would invest 0.00 in Cocrystal Pharma on February 27, 2024 and sell it all today you would earn a total of 0.00 from holding Cocrystal Pharma or generate 0.0% return on investment in Cocrystal Pharma over 30 days. Cocrystal Pharma is related to or competes with Madrigal Pharmaceuticals, 23Andme Holding, Moleculin Biotech, Equillium, Mustang Bio, Seres Therapeutics, and Agilent Technologies. Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treat... More
Cocrystal Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cocrystal Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cocrystal Pharma upside and downside potential and time the market with a certain degree of confidence.
Information Ratio | (0.16) | |||
Maximum Drawdown | 15.13 | |||
Value At Risk | (4.55) | |||
Potential Upside | 3.5 |
Cocrystal Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cocrystal Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cocrystal Pharma's standard deviation. In reality, there are many statistical measures that can use Cocrystal Pharma historical prices to predict the future Cocrystal Pharma's volatility.Risk Adjusted Performance | (0.05) | |||
Jensen Alpha | (0.33) | |||
Total Risk Alpha | (0.94) | |||
Treynor Ratio | (6.40) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cocrystal Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cocrystal Pharma Backtested Returns
Cocrystal Pharma secures Sharpe Ratio (or Efficiency) of -0.0984, which signifies that the company had a -0.0984% return per unit of standard deviation over the last 3 months. Cocrystal Pharma exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cocrystal Pharma's risk adjusted performance of (0.05), and Mean Deviation of 2.17 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.0502, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Cocrystal Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Cocrystal Pharma is expected to be smaller as well. Cocrystal Pharma has an expected return of -0.29%. Please make sure to confirm Cocrystal Pharma jensen alpha, as well as the relationship between the skewness and day median price , to decide if Cocrystal Pharma performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.04 |
Virtually no predictability
Cocrystal Pharma has virtually no predictability. Overlapping area represents the amount of predictability between Cocrystal Pharma time series from 27th of February 2024 to 13th of March 2024 and 13th of March 2024 to 28th of March 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cocrystal Pharma price movement. The serial correlation of 0.04 indicates that only as little as 4.0% of current Cocrystal Pharma price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.04 | |
Spearman Rank Test | -0.01 | |
Residual Average | 0.0 | |
Price Variance | 0.0 |
Cocrystal Pharma lagged returns against current returns
Autocorrelation, which is Cocrystal Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cocrystal Pharma's stock expected returns. We can calculate the autocorrelation of Cocrystal Pharma returns to help us make a trade decision. For example, suppose you find that Cocrystal Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Cocrystal Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cocrystal Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cocrystal Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cocrystal Pharma stock over time.
Current vs Lagged Prices |
Timeline |
Cocrystal Pharma Lagged Returns
When evaluating Cocrystal Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cocrystal Pharma stock have on its future price. Cocrystal Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cocrystal Pharma autocorrelation shows the relationship between Cocrystal Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in Cocrystal Pharma.
Regressed Prices |
Timeline |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cocrystal Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cocrystal Pharma's short interest history, or implied volatility extrapolated from Cocrystal Pharma options trading.
Pair Trading with Cocrystal Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cocrystal Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cocrystal Pharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Cocrystal Stock
0.64 | MBRX | Moleculin Biotech Financial Report 9th of May 2024 | PairCorr |
0.71 | MCRB | Seres Therapeutics Financial Report 14th of May 2024 | PairCorr |
Moving against Cocrystal Stock
0.83 | DNTH | Dianthus Therapeutics Symbol Change | PairCorr |
0.8 | MGNX | MacroGenics Financial Report 14th of May 2024 | PairCorr |
0.8 | MRK | Merck Company Fiscal Quarter End 31st of March 2024 | PairCorr |
0.76 | EQ | Equillium Financial Report 9th of May 2024 | PairCorr |
0.71 | MDWD | Mediwound Downward Rally | PairCorr |
The ability to find closely correlated positions to Cocrystal Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cocrystal Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cocrystal Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cocrystal Pharma to buy it.
The correlation of Cocrystal Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cocrystal Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cocrystal Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cocrystal Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Cocrystal Pharma Correlation, Cocrystal Pharma Volatility and Cocrystal Pharma Alpha and Beta module to complement your research on Cocrystal Pharma. To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.Note that the Cocrystal Pharma information on this page should be used as a complementary analysis to other Cocrystal Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Cocrystal Stock analysis
When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Cocrystal Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.